Thursday July 18, 6:03 pm Eastern Time
Press Release
SOURCE: Moneyzone.com
Moneyzone.com, Inc. Acquires Quick Test 5, Inc.
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--July 18, 2002-- Moneyzone.com,
Inc. (OTCBB:MOZN - NEWS) is pleased to announce that, pursuant to an Agreement
and Plan for Reorganization, it has acquired 100% of the outstanding common
stock of Quick Test 5, Inc. ("QT5"), a privately held company. Upon the closing
of the transaction, Moneyzone.com will perform a 5-for-1 forward split and issue
an aggregate of 25,000,000 shares of its common stock, existing officers and
directors of Moneyzone.com will resign, and the officers and directors of QT5
will be the new officers and directors of Moneyzone.com, and Moneyzone.com will
change its name to QT5, Inc. and apply for a new symbol for trading on the OTC.
The closing of the transaction is subject to shareholder approval and
appropriate notification will be sent to shareholders.
The Company
Quick Test 5, Inc. is a developer, distributor, and marketer. The first product
to market is Nico Water, a patented water-based nicotine product targeted to
smokers for when they shouldn't or can't smoke (around children or nonsmoking
environments). Nico Water will be the first nicotine beverage on the market.
This patented product is covered under U.S. Patent Number 6,268,386 and has been
assigned to QT5 for its duration in the United States and worldwide
distribution. This is a broad-based fundamental patent that provides for several
new products over the next 2 years.
Our second product, QuickTest 5, a No Step, In Vitro Urine Analysis Drug Test to
the retail over the counter, business, industrial, schools, and government
markets. To date, we have been engaged in the research and development of
proprietary programs for business and government use to educate and limit
liability of employee drug use, sexual harassment and work place discrimination.
We have aligned ourselves with a manufacturer of In Vitro Drug Test devices,
that are patented and/or patent-pending and F.D.A. approved for the sale to the
general public through a wide range of retail venues including: drug stores,
health food stores and supermarkets.
Forward-Looking Statement
The statements in this news release contain forward-looking information and
statements, which may involve certain risks, assumptions and uncertainties,
including the inability to secure the necessary approvals from the FDA, the lack
of acceptance of the company's products by its customers and prospects, the
inability to secure the necessary product sales and the inability to obtain
necessary substantial additional capital to manufacture and market its product
and otherwise implement its business plan. In each case, actual results may
differ materially from such forward-looking statements. Neither Moneyzone.com
nor QT5 undertake to publicly update or revise its forward-looking statements,
even if experience or future changes make it clear that any projected results
(expressed or modified) will not be realized.
Contact:
Quick Test 5, Inc.
Timothy J. Owens, 818/338-1510
tim@nicowater.net
